These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19277416)

  • 1. Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisation.
    Chia S; Van Cott EM; Raffel OC; Jang IK
    Thromb Haemost; 2009 Mar; 101(3):535-40. PubMed ID: 19277416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation monitoring during vascular surgery: accuracy of the Hemochron low range activated clotting time (ACT-LR).
    Tremey B; Szekely B; Schlumberger S; François D; Liu N; Sievert K; Fischler M
    Br J Anaesth; 2006 Oct; 97(4):453-9. PubMed ID: 16873382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point-of-care measurement of activated clotting time for cardiac surgery as measured by the Hemochron signature elite and the Abbott i-STAT: agreement, concordance, and clinical reliability.
    Dirkmann D; Nagy E; Britten MW; Peters J
    BMC Anesthesiol; 2019 Sep; 19(1):174. PubMed ID: 31492108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between activated clotting time and anti-activated factor X activity for the monitoring of unfractionated heparin therapy in patients with aortic aneurysm undergoing an endovascular procedure.
    Dieplinger B; Egger M; Luft C; Hinterreiter F; Pernerstorfer T; Haltmayer M; Mueller T
    J Vasc Surg; 2018 Aug; 68(2):400-407. PubMed ID: 29571622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test.
    Paniccia R; Fedi S; Carbonetto F; Noferi D; Conti P; Bandinelli B; Giusti B; Evangelisti L; Pretelli P; Palmarini MF; Abbate R; Prisco D
    Anesthesiology; 2003 Jul; 99(1):54-9. PubMed ID: 12826842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bedside coagulometry during intravenous heparin therapy after coronary angioplasty.
    Schroeder AP; Knudsen LL; Husted SE; Knudsen L; Ingerslev J
    J Thromb Thrombolysis; 2001 Oct; 12(2):157-63. PubMed ID: 11729367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Heparin Anticoagulation Measured Using i-STAT and Hemochron Activated Clotting Time.
    Maslow A; Chambers A; Cheves T; Sweeney J
    J Cardiothorac Vasc Anesth; 2018 Aug; 32(4):1603-1608. PubMed ID: 29503117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintaining adequate anticoagulation on extracorporeal membrane oxygenation therapy: Hemochron Junior Low Range versus Hemochron 400.
    Colby CE; Sheehan A; Benitz W; Van Meurs K; Halamek LP; Moss RL
    J Extra Corpor Technol; 2003 Mar; 35(1):35-8. PubMed ID: 12680494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enoxaparin anticoagulation monitoring in the catheterization laboratory using a new bedside test.
    Silvain J; Beygui F; Ankri A; Bellemain-Appaix A; Pena A; Barthelemy O; Cayla G; Gallois V; Galier S; Costagliola D; Collet JP; Montalescot G
    J Am Coll Cardiol; 2010 Feb; 55(7):617-25. PubMed ID: 20170785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative Monitoring of Heparin: Comparison of Activated Coagulation Time and Whole Blood Heparin Measurements by Different Point-of-Care Devices with Heparin Concentration by Laboratory-Performed Plasma Anti-Xa Assay.
    Thompson TZ; Kunak RL; Savage NM; Agarwal S; Chazelle J; Singh G
    Lab Med; 2019 Oct; 50(4):348-356. PubMed ID: 31053856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hemochron Response RxDx heparin and protamine dosing system.
    Jaryno SA; Zucker ML; LaDuca FM
    J Extra Corpor Technol; 2004 Sep; 36(3):258-62. PubMed ID: 15559745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients.
    Kim H; Szlam F; Tanaka KA; van de Locht A; Ogawa S; Levy JH
    Anesth Analg; 2012 Aug; 115(2):244-52. PubMed ID: 22584552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of ACT point-of-care measurements: repeatability and agreement.
    Bosch YP; Ganushchak YM; de Jong DS
    Perfusion; 2006 Jan; 21(1):27-31. PubMed ID: 16485696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring high-dose heparin levels by ACT and HMT during extracorporeal circulation: diagnostic accuracy of three compact monitors.
    Giavarina D; Carta M; Fabbri A; Manfredi J; Gasparotto E; Soffiati G
    Perfusion; 2002 Jan; 17(1):23-6. PubMed ID: 11817524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of a microsample coagulation analyzer, and comparison with existing techniques.
    Carter AJ; Hicks K; Heldman AW; Resar JR; Laird JR; Coombs VJ; Brinker JA; Blumenthal RS
    Cathet Cardiovasc Diagn; 1996 Sep; 39(1):97-102. PubMed ID: 8874958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative trial of anti-factor Xa levels versus the activated partial thromboplastin time for heparin monitoring.
    Vandiver JW; Vondracek TG
    Hosp Pract (1995); 2013 Apr; 41(2):16-24. PubMed ID: 23545756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin monitoring during cardiopulmonary bypass surgery using the one-step point-of-care whole blood anti-factor-Xa clotting assay heptest-POC-Hi.
    Hellstern P; Bach J; Simon M; Saggau W
    J Extra Corpor Technol; 2007 Jun; 39(2):81-6. PubMed ID: 17672188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of ACT as measured with three commercially available devices with circulating heparin level during cardiac surgery.
    Niles SD; Sutton RG; Ploessl J; Pennell B
    J Extra Corpor Technol; 1995 Dec; 27(4):197-200. PubMed ID: 10172651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
    Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.